Bouros D, Antoniou K M, Chalkiadakis G, Drositis J, Petrakis I, Siafakas N
Department of Pneumonology, University Hospital, Heraklion, 711 10 Crete, Greece.
Surg Endosc. 2002 Jan;16(1):151-4. doi: 10.1007/s00464-001-9028-3. Epub 2001 Oct 19.
Approximately 10% of patients treated with intrapleural instillation of fibrinolytics fail to respond and therefore need more invasive techniques, such as video-assisted thoracoscopic surgery (VATS).
During the period 1994-99, we treated 20 consecutive patients with complicated parapneumonic effusion (CPE) and pleural empyema (PE) that did not resolve with urokinase instillation given through the chest tube in a dose of 100,000 IU diluted in 100 ml of normal saline/daily for 3-5 days. The patients' ages ranged from 21 to 68 years (median, 46); 14 were male and six female. All patients had pleural fluid pH <7.1, LACTATE DEHYDRAGENASE (LDH) >1000, glucose <40 mg/dl and were submitted to VATS.
Complete drainage was observed in 17 patients (85%), in the other three (15%), the procedure had to be converted to open thoracotomy due to a thickened visceral pleural peel. The mean operative time was 80.3 min (range, 55-140), and the mean duration of postoperative hospital stay was 7.5 days (range, 4-19).
We found that VATS is a safe, effective, and well-tolerated surgical procedure in CPE and PE patients who have failed to resolve with initial treatment with fibrinolytics.
接受胸膜腔内注入纤维蛋白溶解剂治疗的患者中,约10%无反应,因此需要更具侵入性的技术,如电视辅助胸腔镜手术(VATS)。
在1994 - 1999年期间,我们连续治疗了20例复杂性类肺炎性胸腔积液(CPE)和胸膜脓胸(PE)患者,这些患者通过胸腔引流管每日注入100,000 IU尿激酶(用100 ml生理盐水稀释),共3 - 5天,但病情未缓解。患者年龄在21至68岁之间(中位数为46岁);14例为男性,6例为女性。所有患者的胸腔积液pH值<7.1,乳酸脱氢酶(LDH)>1000,葡萄糖<40 mg/dl,并接受了VATS手术。
17例患者(85%)实现了完全引流,另外3例(15%)由于脏层胸膜增厚粘连,手术不得不转为开胸手术。平均手术时间为80.3分钟(范围55 - 140分钟),术后平均住院时间为7.5天(范围4 - 19天)。
我们发现,对于初始纤维蛋白溶解剂治疗无效的CPE和PE患者,VATS是一种安全、有效且耐受性良好的手术方法。